A recent study mechanistically demonstrated that loss of the ATP synthase subunit ATP5H is strongly linked to multimodal cancer therapy resistance and poor survival in cancer patients, and the mechanism is mediated by ROS accumulation and HIF-1 α stabilization that confers to tumor cells a stem-like and invasive phenotype [54]. This evidence concerns the gene SETD2 and cancer.